Examples of using Parallel exports in English and their translations into Bulgarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
An initiative to ban parallel exports of life-sustaining drugs has started online.
Competition- Community rules- Scope ratione materiae- Practices aimed at preventing or restricting parallel exports- Included.
Key words: parallel exports, drug products for oncological diseases, Bulgaria.
(Article 82 EC- Abuse of dominant position- Pharmaceutical products- Refusal to supply wholesalers engaging in parallel exports- Ordinary orders).
An initiative to ban parallel exports of life-sustaining drugs has started online.
The conference aims to provide a platform for discussion on key issues related to drug deficiency, legal possibilities ande-solutions to regulate parallel exports as well as securing effective medicines at affordable prices.
Key words: parallel exports, drug products for oncological diseases, Bulgaria Address for correspondence: Prof.
The conference aims to provide a platform for discussion on key issues related to drug deficiency, legal possibilities ande-solutions to regulate parallel exports as well as securing effective medicines at affordable prices.
In that connection, it should be noted that parallel exports of medicinal products from a Member State where the prices are low to other Member States in which the.
Lélos kai Sia EE and Others v GlaxoSmithKline AEVE Farmakeftikon Proionton,formerly Glaxowellcome AEVE(Article 82 EC- Abuse of dominant position- Pharmaceutical products- Refusal to supply wholesalers engaging in parallel exports- Ordinary orders)(References for a preliminary ruling from the Efetio Athinon).
An economic analysis and assessment of the value of parallel exports of drug products for treatment of oncological diseases in Bulgaria in 2016- Medical Review(Medicinski pregled), 53, 2017,№4, 52-57.
Competition- Agreements, decisions and concerted practices- Market for Nintendo video games consoles andgames cartridges- Decision finding an infringement of Article 81 EC- Limitation of parallel exports- Proof of the existence of an agreement to limit parallel trade- Fines- Differential treatment- Attenuating circumstances.
Parallel exports of medicinal products subject to medical prescription will be made after notification to the Bulgarian Drug Agency(BDA) and the Director of the Agency will be able to refuse with a reasoned order as long as it is established that the product is in limited amounts in Bulgaria.
Abstract: The aim of the study is the analysis and assessment of parallel exports from Bulgaria of drug products for treatment of oncological diseases with annual sales of more than BGN 3 million in 2016.
According to the Advocate General,the contractual obligation linked to the broadcasting licences requiring the broadcaster to prevent its satellite decoder cards from being used outside the licensed territory has the same effect as agreements to prevent or restrict parallel exports.
Thus, agreements aimed at partitioning national markets according to national borders or making the interpenetration of national markets more difficult,in particular those aimed at preventing or restricting parallel exports, have been held by the Community judicature to be agreements whose object is to restrict competition within the meaning of that article of the Treaty.
A contractual obligation linked to a broadcasting licence requiring the broadcaster to prevent its satellite decoder cards which enable reception of the licensed programme content from being used outside the licensed territory has the same effect as agreements to prevent or restrict parallel exports.
Thus on a number of occasions the Court has held agreements aimed at partitioning national markets according to national borders or making the interpenetration of national markets more difficult,in particular those aimed at preventing or restricting parallel exports, to be agreements whose object is to restrict competition within the meaning of that Treaty article.
Thus on a number of occasions the Court has held agreements aimed at partitioning national markets according to national borders or making the interpenetration of national markets more difficult,in particular those aimed at preventing or restricting parallel exports, to be agreements whose object is to restrict competition within the meaning of that Treaty article.
It must be examined in this context whether, as GSK AEVE claims, particular circumstances are present in the pharmaceuticals sector,by reason of which the refusal by an undertaking in a dominant position to supply clients in a given Member State who engage in parallel exports to other Member States where prices for medicines are higher does not, generally speaking, constitute an abuse.
In the light of the abovementioned Treaty objective as well as that of ensuring that competition in the internal market is not distorted,there can be no escape from the prohibition laid down in Article 82 EC for the practices of an undertaking in a dominant position which are aimed at avoiding all parallel exports from a Member State to other Member States, practices which, by partitioning the national markets.
The parallel export of medicines was restricted.
The parallel export of medicinal products from Bulgaria is regulated in the latest Bill amending the Medicinal Products for Human Use Act.
C MPHUA regarding parallel export of medicinal products before the Constitutional Court.
The bill regulates the export of medicinal products(including the so-called“parallel export”), sets forth further obligations of marketing authorisation holders in relation to suspension of the marketing of medicinal products, provides for a new regulatory body- Expert Council on Retail Sale of Medicinal Products, and contains detailed rules on the Urgent Union Procedure, implementing Directive 2012/26/EC.
Ministers also discussed issues related to the effectiveness and accessibility of medicines,including patients' problems caused by parallel drug exports.
Parallel imports and exports of medicinal products is a lawful form of trade within the Single Market.
Parallel imports and exports of medicinal products is a lawful form of trade within the Single Market.
Parallel imports and exports of medicinal products are compatible with the free movement of goods(Article 34 of TFEU).
Parallel imports and exports of medicinal products are protected under free movement of goods rules(set out in Article 34 TFEU).